Rare diseases
Investigational molecules
Locations
Back to Germany46 clinical trials in Dessau-Roßlau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of SAR444656 for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
GermanyGermanyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Effects of Ribociclib and Endocrine Therapy for Patients with HR-Positive, HER2-Negative Early Breast Cancer
GermanyStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
GermanyGermanyComparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant
GermanyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on breast cancer treatments, including trials for HER2-positive, hormone receptor-positive, and triple-negative variants. Research includes novel combination therapies and targeted treatments.
Notable investigations into pre-operative and post-resection treatments for various cancer types.
Innovative research addressing cardiovascular disease and cholesterol management, with trials evaluating new treatments for reducing cardiovascular events and managing lipid levels.
Focus on developing new therapeutic approaches for cardiovascular health improvement.
Clinical investigations of treatments for severe skin conditions, particularly focusing on hidradenitis suppurativa and other inflammatory skin disorders.
Evaluation of novel therapeutic agents for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
